PubRank

Michel Noutsias

Author PubWeight™ 42.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 2005 3.06
2 Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 2003 2.33
3 Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 2005 2.15
4 Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer. J Clin Oncol 2006 1.88
5 Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 2008 1.87
6 Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 2008 1.31
7 Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 2007 1.27
8 Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy. Diabetes 2007 1.20
9 In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer. J Transl Med 2006 1.15
10 Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy. FASEB J 2005 1.11
11 Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. FASEB J 2004 1.08
12 Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer. J Cancer Res Clin Oncol 2008 1.02
13 Viral myocarditis and coagulopathy: increased tissue factor expression and plasma thrombogenicity. J Mol Cell Cardiol 2008 1.00
14 Autoimmunological features in inflammatory cardiomyopathy. Clin Res Cardiol 2007 0.99
15 Induction of coxsackievirus-adenovirus-receptor expression during myocardial tissue formation and remodeling: identification of a cell-to-cell contact-dependent regulatory mechanism. Circulation 2003 0.97
16 Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction. Cardiovasc Res 2002 0.96
17 Protection against oxidative stress in diabetic rats: role of angiotensin AT(1) receptor and beta 1-adrenoceptor antagonism. Eur J Pharmacol 2005 0.94
18 Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy. Ther Apher Dial 2006 0.90
19 Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis. Eur J Pharmacol 2006 0.87
20 NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy. PLoS One 2008 0.86
21 Viral heart disease: molecular diagnosis, clinical prognosis, and treatment strategies. Med Microbiol Immunol 2004 0.85
22 Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy. Med Sci Monit 2008 0.84
23 Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response. Eur J Heart Fail 2005 0.84
24 Immunoglobulin G3 cardiac myosin autoantibodies correlate with left ventricular dysfunction in patients with dilated cardiomyopathy: immunoglobulin G3 and clinical correlates. Am Heart J 2002 0.84
25 Left ventricular enlargement in coxsackievirus-B3 induced chronic myocarditis--ongoing inflammation and an imbalance of the matrix degrading system. Eur J Pharmacol 2009 0.83
26 Adventitial VEGF165 gene transfer prevents lumen loss through induction of positive arterial remodeling after PTCA in porcine coronary arteries. Atherosclerosis 2006 0.83
27 Adaptive immune responses against parvovirus B19 in patients with myocardial disease. J Clin Virol 2008 0.82
28 Giant-cell myocarditis in a patient presenting with dilated cardiomyopathy and ventricular tachycardias treated by immunosuppression: a case report. Int J Cardiol 2007 0.81
29 Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathy. Am J Pathol 2011 0.80
30 Generation of HCMV-specific T-cell lines from seropositive solid-organ-transplant recipients for adoptive T-cell therapy. J Immunother 2009 0.80
31 Recurrent coxsackie B viral myocarditis leading to progressive impairment of left ventricular function over 8 years. Int J Cardiol 2010 0.79
32 Cardiomyopathies: classification, diagnosis, and treatment. Heart Fail Clin 2012 0.79
33 Effect of adventitial VEGF(165) gene transfer on vascular thickening after coronary artery balloon injury. Cardiovasc Res 2003 0.79
34 [Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy]. Herz 2002 0.78
35 Detection of clonal T-cell-receptor (TCR) Vbeta rearrangements in explanted dilated cardiomyopathy hearts by semi-nested PCR, GeneScan, and direct sequencing. Med Sci Monit Basic Res 2013 0.77
36 Immunoadsorption and subsequent immunoglobulin substitution decreases myocardial gene expression of desmin in dilated cardiomyopathy. J Mol Med (Berl) 2007 0.76
37 Intramyocardial inflammation in dilated cardiomyopathy--what makes a difference? Med Sci Monit 2002 0.75
38 Diagnostic endomyocardial biopsy interpretation. Can J Cardiol 2003 0.75
39 Immunohistological detection of Parvovirus B19 capsid proteins in endomyocardial biopsies from dilated cardiomyopathy patients. Med Sci Monit 2008 0.75
40 Immunosuppressive treatment in familial dilated cardiomyopathy with biopsy-proven intramyocardial inflammation? J Am Coll Cardiol 2003 0.75
41 Pathophysiological mechanisms of parvovirus B19 infection. J Clin Microbiol 2009 0.75
42 [Antiviral therapy in viral heart disease]. Herz 2004 0.75
43 Impact of cell culture media on the expansion efficiency and T-cell receptor Vbeta (TRBV) repertoire of in vitro expanded T cells using feeder cells. Med Sci Monit 2008 0.75